首页> 外国专利> USE OF THERAPEUTIC ENZYME FUSION PROTEIN FOR PREVENTING AND TREATING KIDNEY DISEASE CAUSED OR ACCOMPANIED BY FABRY'S DISEASE

USE OF THERAPEUTIC ENZYME FUSION PROTEIN FOR PREVENTING AND TREATING KIDNEY DISEASE CAUSED OR ACCOMPANIED BY FABRY'S DISEASE

机译：治疗性酶融合蛋白在预防和治疗由法布里病引起或伴有法布里病的肾病中的应用

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a use of a fusion protein of a therapeutic enzyme and an immunoglobulin Fc region, the use being for the prevention or alleviation of a kidney disease caused or accompanied by Fabry's disease.

机译：本发明涉及治疗酶和免疫球蛋白Fc区的融合蛋白的用途，该用途用于预防或缓解由法布里氏病引起或伴随的肾病。

著录项

公开/公告号WO2022103221A1

专利类型
公开/公告日2022-05-19

原文格式PDF
申请/专利权人 HANMI PHARM. CO. LTD.;
展开▼

申请/专利号WO2021KR16630
发明设计人 CHOI JAE HYUK;KIM JIN YOUNG;PARK CHO RONG;KIM SANG YUN;KIM JEONG A;JANG DOO SEO;
展开▼

申请日2021-11-15
分类号A61K38;A61K38/47;A61K47/68;A61P13/12;
国家 KR
入库时间 2022-08-25 01:08:21

相似文献

专利
外文文献
中文文献